CPT1A and pulmonary fibrosis: Genetic and pharmacological disruption of carnitine palmitoyltransferase 1a (CPT1a) modulates in vitro and in vivo AT2 differentiation by promoting accumulation of aberrant basaloid and airway secretory intermediate cells and reducing the resistance to developing lung fibrosis after injury.